References:
1. Subasty J. A Study to Assess the Effectiveness of Information Booklet
on Prevention of COVID19 among Adolescents at Selected Village,
Coimbatore: PPG College of Nursing, Coimbatore; 2021.
2. Hopkins C, Kumar N. Loss of sense of smell as marker of COVID-19
infection. The Royal College of Surgeons of England: British
Rhinological Society. 2020:1-2.
3. Kanjanaumporn J, Aeumjaturapat S, Snidvongs K, Seresirikachorn K,
Chusakul S. Smell and taste dysfunction in patients with SARS-CoV-2
infection: A review of epidemiology, pathogenesis, prognosis, and
treatment options. Asian Pacific Journal of Allergy and Immunology.
2020;38(2):69-77.
4. van Eijk LE, Binkhorst M, Bourgonje AR, Offringa AK, Mulder DJ, Bos
EM, et al. COVID‐19: immunopathology, pathophysiological mechanisms, and
treatment options. The Journal of pathology. 2021;254(4):307-31.
5. Boesveldt S, Postma EM, Boak D, Welge-Luessen A, Schöpf V, Mainland
JD, et al. Anosmia—a clinical review. Chemical senses.
2017;42(7):513-23.
6. Lee DY, Lee WH, Wee JH, Kim J-W. Prognosis of postviral olfactory
loss: follow-up study for longer than one year. American journal of
rhinology & allergy. 2014;28(5):419-22.
7. Klimek L, Hagemann J, Döge J, Freudelsperger L, Cuevas M, Klimek F,
et al. Olfactory and gustatory disorders in COVID-19. Allergo journal
international. 2022;31(7):243-50.
8. Li J, Liu H-H, Yin X-D, Li C-C, Wang J. COVID-19 illness and
autoimmune diseases: recent insights. Inflammation Research.
2021;70:407-28.
9. Di Stadio A, D’Ascanio L, Vaira LA, Cantone E, De Luca P, Cingolani
C, et al. Ultramicronized palmitoylethanolamide and luteolin supplement
combined with olfactory training to treat post-COVID-19 olfactory
impairment: a multi-center double-blinded randomized placebo-controlled
clinical trial. Current neuropharmacology. 2022;20(10):2001-12.
10. Saussez S, Vaira LA, Chiesa-Estomba CM, Le Bon SD, Horoi M, Deiana
G, et al. Short-term efficacy and safety of oral and nasal
corticosteroids in COVID-19 patients with olfactory dysfunction: a
European multicenter study. Pathogens. 2021;10(06):698.
11. Duncan RB, Briggs M. Treatment of uncomplicated anosmia by vitamin
A. Archives of otolaryngology. 1962;75(2):116-24.
12. Hummel T, Whitcroft KL, Rueter G, Haehner A. Intranasal vitamin A is
beneficial in post-infectious olfactory loss. European Archives of
Oto-rhino-laryngology. 2017;274:2819-25.
13. Henkin RI, Velicu I, Schmidt L. An open-label controlled trial of
theophylline for treatment of patients with hyposmia. The American
journal of the medical sciences. 2009;337(6):396-406.
14. Henkin RI, Schultz M, Minnick-Poppe L. Intranasal theophylline
treatment of hyposmia and hypogeusia: a pilot study. Archives of
Otolaryngology–Head & Neck Surgery. 2012;138(11):1064-70.
15. Addison AB, Wong B, Ahmed T, Macchi A, Konstantinidis I, Huart C, et
al. Clinical Olfactory Working Group consensus statement on the
treatment of postinfectious olfactory dysfunction. Journal of Allergy
and Clinical Immunology. 2021;147(5):1704-19.
16. El-Anwar MW, Elzayat S, Fouad YA. ENT manifestation in COVID-19
patients. Auris Nasus Larynx. 2020;47(4):559-64.
17. Luers J, Rokohl A, Loreck N, Wawer Matos P, Augustin M, Dewald F.
Olfactory and gustatory dysfunction in coronavirus disease 19 (COVID-19)
Clin Infect Dis. 2020;(May) doi: 10.1093/cid/ciaa525. Published
online[Europe PMC free article][Abstract][CrossRef][Google
Scholar].
18. Lv H, Zhang W, Zhu Z, Xiong Q, Xiang R, Wang Y, et al. Prevalence
and recovery time of olfactory and gustatory dysfunction in hospitalized
patients with COVID‑19 in Wuhan, China. International Journal of
Infectious Diseases. 2020;100:507-12.
19. Le Bon S-D, Konopnicki D, Pisarski N, Prunier L, Lechien JR, Horoi
M. Efficacy and safety of oral corticosteroids and olfactory training in
the management of COVID-19-related loss of smell. European Archives of
Oto-rhino-laryngology. 2021;278:3113-7.
20. Abdelalim AA, Mohamady AA, Elsayed RA, Elawady MA, Ghallab AF.
Corticosteroid nasal spray for recovery of smell sensation in COVID-19
patients: a randomized controlled trial. American journal of
otolaryngology. 2021;42(2):102884.
21. Hintschich CA, Dietz M, Haehner A, Hummel T. Topical administration
of mometasone is not helpful in post-COVID-19 olfactory dysfunction.
Life. 2022;12(10):1483.
22. Hummel T, Whitcroft KL, Rueter G, Haehner A. Intranasal vitamin A is
beneficial in post-infectious olfactory loss. European Archives of
Oto-Rhino-Laryngology. 2017;274(7):2819-25.
23. Gupta S, Lee JJ, Perrin A, Khan A, Smith HJ, Farrell N, et al.
Efficacy and safety of saline nasal irrigation plus theophylline for
treatment of COVID-19–related olfactory dysfunction: the SCENT2 phase 2
randomized clinical trial. JAMA Otolaryngology–Head & Neck Surgery.
2022;148(9):830-7.
24. Lee JJ, Peterson AM, Kallogjeri D, Jiramongkolchai P, Kukuljan S,
Schneider JS, et al. Smell Changes and Efficacy of Nasal Theophylline
(SCENT) irrigation: A randomized controlled trial for treatment of
post-viral olfactory dysfunction. American journal of otolaryngology.
2022;43(2):103299.
25. Esquinas-Requena JL, Lozoya-Moreno S, García-Nogueras I,
Atienzar-Núñez P, Sánchez-Jurado PM, Abizanda P. La anemia aumenta el
riesgo de mortalidad debido a fragilidad y discapacidad en mayores:
Estudio FRADEA. Atencion primaria. 2020;52(7):452-61.